Global Future Council on Antimicrobial Resistance

Global Future Council on Antimicrobial Resistance

Antimicrobial resistance (AMR) is already a leading cause of death globally, higher than HIV/AIDS or malaria. What novel approaches are needed to accelerate effective action on AMR?

Members
Antimicrobial Resistance Control and One Health Unit Lead, Africa Centres for Disease Control and Prevention (Africa CDC)
Yewande Alimi
Visiting Senior Fellow, LSE Health, London School of Economics and Political Science
Michael Anderson
Chief, External Affairs, CARB-X
Damiano de Felice
South African Research Chair in Antibiotic Resistance and One Health; Professor in Pharmaceutical Sciences, University of KwaZulu-Natal
Sabiha Essack
Director, Global Public Policy, MSD
Gregory Frank
Principal, Antimicrobial Resistance, IQVIA
Rachel Freeman
Vice President, Head of Infectious Diseases, Novo Nordisk Foundation
Marianne Holm
Professor of Infectious Diseases; Director, Fleming Initiative, Imperial College London
Alison Holmes
Head of Policy, Infectious Disease, Wellcome Trust
Jeremy Knox
Director, Investment Stewardship, Asset Management, Legal & General Group
Maria Larsson Ortino
Policy Fellow, Center for Global Development
Anthony McDonnell​
Country Director, Nigeria, PharmAccess Foundation
Njide Ndili
Coordinator, Antimicrobial Resistance and Infection Prevention and Control Programme, Nigeria Centre for Disease Control (CDC)
Tochi Okwor
Director, International Policy, AMR Action Fund
Deepali Patel
Professor, School of Public Health, Peking University
Ren Minghui
Editor-in-Chief, AMR.Solutions
John Rex
Senior Health Specialist, World Bank Group
Naomi Rupasinghe​
Deputy Director, Bill & Melinda Gates Foundation
Padmini Srikantiah
Chair, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Jeffrey L. Sturchio

相关内容 报告

相关内容 视频

关于我们

  • 我们的任务
  • 我们的历史
  • 领导团队
  • 影响力

更多内容

加入我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛